DeepMed Research

UNIVERSITY OF CALIFORNIA, DAVIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1905-01-01

Employees: 10K

Market Cap: -

Website: http://www.ucdavis.edu

Clinical Trials

Micropulse for Suppression of Diabetic Macular Edema

Not Applicable

Completed

Conditions: Diabetic Macular Edema

Interventions: Device: Micropulse Laser Treatment
Device: Sham Treatment

First Posted Date: 2018-05-09

Last Posted Date: 2024-12-17

Lead Sponsor: University of California, Davis

Target Recruit Count: 19

Registration Number: NCT03519581

Locations: 🇺🇸
University of California, Davis, Sacramento, California, United States

Use of Virtual Reality Game Playing During Venipuncture

Not Applicable

Completed

Conditions: Development Delay
Typical Development
Autism

Interventions: Behavioral: Virtual Reality
Behavioral: Standard of Care

First Posted Date: 2018-05-08

Last Posted Date: 2019-05-15

Lead Sponsor: University of California, Davis

Target Recruit Count: 12

Registration Number: NCT03518346

Locations: 🇺🇸
University of California Davis MIND Institute, Sacramento, California, United States

Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

Phase 3

Completed

Conditions: Hiv

Interventions: Other: Service of care

First Posted Date: 2018-05-07

Last Posted Date: 2020-07-31

Lead Sponsor: University of California, Davis

Target Recruit Count: 10

Registration Number: NCT03517358

Locations: 🇺🇸
One Community Health, Sacramento, California, United States

ED Treatment of Suicidal Patients With Ketamine Infusion

Phase 2

Withdrawn

Conditions: Suicide
Suicidal Ideation

Interventions: Drug: Ketamine

First Posted Date: 2018-04-18

Last Posted Date: 2019-05-01

Lead Sponsor: University of California, Davis

Registration Number: NCT03502551

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

Effects of Prolonged Fasting on Microbiome and HDL

Not Applicable

Completed

Conditions: Fasting

Interventions: Other: Fasting

First Posted Date: 2018-04-04

Last Posted Date: 2018-09-27

Lead Sponsor: University of California, Davis

Target Recruit Count: 21

Registration Number: NCT03487679

Locations: 🇺🇸
University of California Davis, Davis, California, United States

A Trial of Metformin in Individuals With Fragile X Syndrome

Phase 2

Completed

Conditions: Fragile X Syndrome
Fragile X Mental Retardation Syndrome
Mental Retardation, X Linked
Genetic Diseases, X-Linked
Trinucleotide Repeat Expansion
Fra(X) Syndrome
Intellectual Disability
FXS
Neurobehavioral Manifestations
Sex Chromosome Disorders

Interventions: Drug: Placebo Medication
Drug: Metformin

First Posted Date: 2018-03-27

Last Posted Date: 2025-01-17

Lead Sponsor: University of California, Davis

Target Recruit Count: 120

Registration Number: NCT03479476

Locations: 🇺🇸
UC Davis MIND Institute, Sacramento, California, United States
🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦
St Justine Hospital, Montréal, Quebec, Canada

Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin

Not Applicable

Completed

Conditions: Wrinkles
Sebum Production
Stool Microbiome
Facial Brrightness
Facial Shine
Erythema
Transepidermal Water Loss

Interventions: Dietary Supplement: Placebo Oral Tablet
Dietary Supplement: Rubia Cordifolia
Dietary Supplement: Triphala

First Posted Date: 2018-03-26

Last Posted Date: 2019-05-15

Lead Sponsor: University of California, Davis

Target Recruit Count: 35

Registration Number: NCT03477825

Locations: 🇺🇸
University of California-Davis, Department of Dermatology, Sacramento, California, United States

Maternal Polyunsaturated Fatty Acids in Association With Child Autism Spectrum Disorder in the MARBLES Study

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Maternal Supplemental PUFA Intake

First Posted Date: 2018-03-19

Last Posted Date: 2023-12-29

Lead Sponsor: University of California, Davis

Target Recruit Count: 252

Registration Number: NCT03468959

Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

Phase 4

Completed

Conditions: Kidney Transplant; Complications
Toxicity
Drug Toxicity
Neurotoxicity

Interventions: Drug: IR Tacrolimus
Drug: Envarsus

First Posted Date: 2018-03-12

Last Posted Date: 2025-04-08

Lead Sponsor: University of California, Davis

Target Recruit Count: 64

Registration Number: NCT03461445

Locations: 🇺🇸
UC Davis, Sacramento, California, United States

Shaping Tolerance for Delayed Rewards

Not Applicable

Recruiting

Conditions: Impulsivity

Interventions: Behavioral: Shaping Delay Tolerance

First Posted Date: 2018-03-07

Last Posted Date: 2024-06-25

Lead Sponsor: University of California, Davis

Target Recruit Count: 50

Registration Number: NCT03457402

Locations: 🇺🇸
UC Davis MIND Institute, Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy